Scott, N., Brown, K., Tak, P. P., Weisel, K., Berger, S., Wang, S., . . . Abbott-Banner, K. A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. BMJ Publishing Group.
Chicago Style (17th ed.) CitationScott, Nicola, et al. A Randomised, Placebo-controlled Study of RIPK1 Inhibitor GSK2982772 in Patients with Active Ulcerative Colitis. BMJ Publishing Group.
MLA (9th ed.) CitationScott, Nicola, et al. A Randomised, Placebo-controlled Study of RIPK1 Inhibitor GSK2982772 in Patients with Active Ulcerative Colitis. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.